Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice.

Infection and Immunity
E Carlson

Abstract

Candida albicans has been shown to stimulate infection in mice by a number of bacteria. Mice inoculated intraperitoneally with as little as 500 colony-forming units of Staphylococcus aureus along with a nonlethal dose of 10(8) colony-forming units of C. albicans (one-third the dose causing 50% mortality in 7 days) developed widespread staphylococcal infection. S. aureus injected alone at that or considerably higher doses did not establish infection. Phage typing methods demonstrated that the staphylococcal infection was due to the bacterial organisms originally injected. A minimum dose of C. albicans between 1.1 X 10(5) and 1.1 X 10(7) colony-forming units was necessary for the amplification of virulence of S. aureus to take place. Serratia marcescens and Streptococcus faecalis inoculated intraperitoneally at small nonlethal doses could also be recovered from blood and tissues 5 days after animals were dually injected with C. albicans but not from animals which were inoculated with the same amounts of these bacteria alone.

References

May 1, 1975·Community Dentistry and Oral Epidemiology·E Budtz-JörgensenM Grabowski
Dec 10, 1981·The New England Journal of Medicine·D T Durack
Jun 1, 1982·Annals of Internal Medicine·B Larsen, R P Galask
Feb 1, 1962·Archives of Dermatology·H I MAIBACH, A M KLIGMAN
Jan 1, 1951·Annals of Internal Medicine·E L KEENEY

❮ Previous
Next ❯

Citations

Jun 26, 2009·FEMS Microbiology Letters·Mark E ShirtliffMary Ann Jabra-Rizk
Oct 7, 2011·World Journal of Surgery·Herman Anthony CarneiroEleftherios Mylonakis
Nov 10, 2013·PLoS Pathogens·Emily M Mallick, Richard J Bennett
Dec 23, 1999·The Journal of Trauma·L N DiebelW J Brown
Jul 1, 2009·Antimicrobial Agents and Chemotherapy·Melphine M Harriott, Mairi C Noverr
Mar 30, 2010·Nature Reviews. Microbiology·Anton Y PelegEleftherios Mylonakis
Jun 23, 2010·Antimicrobial Agents and Chemotherapy·Melphine M Harriott, Mairi C Noverr
Nov 12, 2010·Medical Mycology·Sanjay H ChotirmallNoel G McElvaney
Jun 16, 2012·Intensive Care Medicine·Jean-Damien Ricard, Damien Roux
Aug 15, 2013·Gut Microbes·Danielle A Garsin, Michael C Lorenz
Dec 1, 2011·Microbiology and Molecular Biology Reviews : MMBR·P Frey-KlettA Sarniguet
Oct 19, 2019·Microorganisms·Filomena NogueiraThomas Lion
May 24, 2019·Pathogens·Wibke KrügerMaria Joanna Niemiec
Jan 11, 2019·Microbiology and Molecular Biology Reviews : MMBR·Aislinn D Rowan-NashPeter Belenky
Nov 28, 2019·Journal de mycologie médicale·C BernardC Imbert
Dec 1, 1995·Microbiological Reviews·R B Ashman, J M Papadimitriou
Jan 13, 2021·Infection and Immunity·Jordan R GastonChelsie E Armbruster
Jun 24, 2016·Microbiology Spectrum·Devon L AllisonMark E Shirtliff

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

© 2021 Meta ULC. All rights reserved